You have 9 free searches left this month | for more free features.

Anti-androgens

Showing 26 - 50 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Prostate Cancer, Prostate Disease Trial in Tampa (Nivolumab, Brachytherapy, External Beam Radiation Therapy)

Recruiting
  • Prostate Cancer
  • Prostate Disease
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
Nov 11, 2022

Castration-resistant Prostate Cancer, Metastatic Cancer, Bone Metastases Trial in Ireland (Xgeva, Xtandi)

Suspended
  • Castration-resistant Prostate Cancer
  • +2 more
  • Galway, Connacht, Ireland
  • +6 more
Apr 23, 2021

Salivary Duct Carcinoma Trial in Nijmegen (Goserelin 10.8 mg, Bicalutamide 50 mg, Dutasteride 0.5 mg)

Not yet recruiting
  • Salivary Duct Carcinoma
  • Goserelin 10.8 mg
  • +2 more
  • Nijmegen, Gelderland, Netherlands
    Radboudumc
Aug 23, 2022

Idiopathic Intracranial Hypertension Trial in Montpellier (Blood punction, Central blood sampling, Intracranial pressure

Not yet recruiting
  • Idiopathic Intracranial Hypertension
  • Blood punction
  • +2 more
  • Montpellier, France
    University Hospital of Montpellier - Gui de Chauliac
Oct 2, 2023

Castration-Sensitive Prostate Carcinoma, Metastatic Malignant Tumor in the Bone, Metastatic Prostate Carcinoma Trial in Seattle

Active, not recruiting
  • Castration-Sensitive Prostate Carcinoma
  • +7 more
  • Antiandrogen Therapy
  • +3 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Sep 8, 2022

Congenital Adrenal Hyperplasia (CAH) Trial run by the NICHD (Flutamide, Letrozole, Hydrocortisone)

Active, not recruiting
  • Congenital Adrenal Hyperplasia (CAH)
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 25, 2023

Polycystic Ovary Syndrome Trial in United States (Tildacerfont, Placebo)

Recruiting
  • Polycystic Ovary Syndrome
  • Clearwater, Florida
  • +7 more
Nov 15, 2022

Prostate Cancer Trial in United States (abiraterone acetate, Prednisone)

Active, not recruiting
  • Prostate Cancer
  • Jonesboro, Arkansas
  • +204 more
Nov 30, 2022

Prostate Cancer, Castration-resistant Prostate Cancer, Metastatic Castration-resistant Prostate Cancer Trial in Baltimore

Recruiting
  • Prostate Cancer
  • +2 more
  • Baltimore, Maryland
    Johns Hopkins Hospital
May 6, 2022

PSA Level Greater Than Two, Stage IV Prostate Adenocarcinoma AJCC v7 Trial in Duarte, South Pasadena (drug, radiation, other)

Active, not recruiting
  • PSA Level Greater Than Two
  • Stage IV Prostate Adenocarcinoma AJCC v7
  • Duarte, California
  • +1 more
Apr 4, 2022

Polycystic Ovary Syndrome Trial in Hull (Survey on patient's perspectives on the development of an structured education

Completed
  • Polycystic Ovary Syndrome
  • Survey on patient's perspectives on the development of an structured education programme for PCOS
  • +4 more
  • Hull, United Kingdom
    Hull University Teaching Hospitals NHS Trust, Academic diabetes,
Nov 21, 2021

Preserving Fertility After Colorectal Cancer Study

Recruiting
  • Colorectal Cancer
    • Nashville, Tennessee
      Vanderbilt-Ingram Cancer Center
    Feb 1, 2022

    Clear Cell Renal Cell Carcinoma, Stage I Renal Cell Cancer Trial in New Brunswick (drug, other, procedure)

    Terminated
    • Clear Cell Renal Cell Carcinoma
    • Stage I Renal Cell Cancer
    • New Brunswick, New Jersey
      Rutgers Cancer Institute of New Jersey
    Sep 14, 2021

    Metastatic Hormone-sensitive Prostate Cancer Trial in United States (androgen-deprivation therapy, docetaxel)

    Active, not recruiting
    • Metastatic Hormone-sensitive Prostate Cancer
    • Anchorage, Alaska
    • +342 more
    Jan 29, 2023

    PCOS, NAFLD, NASH Trial in San Francisco, Durham

    Recruiting
    • PCOS
    • +2 more
      • San Francisco, California
      • +1 more
      Nov 3, 2023

      Prostate Cancer Trial in France (drug, procedure, radiation)

      Completed
      • Prostate Cancer
      • Angers, France
      • +37 more
      Jan 17, 2023

      Castration-Resistant Prostate Carcinoma, Metastatic Malignant Tumor in the Bone, Metastatic Malignant Tumor in the Soft Tissues

      Active, not recruiting
      • Castration-Resistant Prostate Carcinoma
      • +6 more
      • San Francisco, California
      • +1 more
      Sep 20, 2022

      Prostate Cancer Trial in Sacramento (Enzalutamide, Metformin Hydrochloride)

      Active, not recruiting
      • Prostate Cancer
      • Sacramento, California
        University of California Davis Comprehensive Cancer Center
      Oct 4, 2022

      Prostate Cancer Trial in Canada, United States (Prednisone, Apalutamide, Abiraterone Acetate)

      Recruiting
      • Prostate Cancer
      • Boston, Massachusetts
      • +5 more
      Jul 14, 2022

      Polycystic Ovary Syndrome Trial in Birmingham (oral androgen challenge with dehydroepiandrosterone (DHEA))

      Recruiting
      • Polycystic Ovary Syndrome
      • oral androgen challenge with dehydroepiandrosterone (DHEA)
      • Birmingham, West Midlands, United Kingdom
        Institute of Metabolism and Systems Research
      Feb 8, 2022

      Castration-resistant Prostate Cancer, Homologous Recombination Deficiency Trial in Sydney (Testosterone Enanthate 100 MG/ML

      Recruiting
      • Castration-resistant Prostate Cancer
      • Homologous Recombination Deficiency
      • Testosterone Enanthate 100 MG/ML Injectable Solution
      • Testosterone Enanthate 100 MG/ML Injectable Solution / Carboplatin AUC 5
      • Sydney, New South Wales, Australia
        Kinghorn Cancer Centre, St. Vincent's Hospital
      Dec 16, 2022

      Hypogonadism Trial in United States (Natesto)

      Recruiting
      • Hypogonadism
      • Birmingham, Alabama
      • +29 more
      Jul 4, 2022

      Covid19, SARS (Severe Acute Respiratory Syndrome) Trial in Manaus (Proxalutamide, Placebo)

      Withdrawn
      • Covid19
      • SARS (Severe Acute Respiratory Syndrome)
      • Manaus, Amazonas, Brazil
        Samel Hospital
      Feb 17, 2022

      Locally Advanced Salivary Gland Carcinoma, Metastatic Salivary Gland Carcinoma, Recurrent Salivary Gland Carcinoma Trial

      Not yet recruiting
      • Locally Advanced Salivary Gland Carcinoma
      • +3 more
      • Biopsy
      • +3 more
      • (no location specified)
      Jan 10, 2023